MS Voice Newsletter – February 2025
Welcome to the February edition of MS Voice—your trusted source for the latest news, updates, and real-life stories from Multiple Sclerosis New Zealand and the MS community. This year promises to be a dynamic one as we continue our commitment to educating, campaigning, and advocating for all those impacted by Multiple Sclerosis. Our focus is clear: […]
Call for Pharmac to Widen Proposed Criteria for Shingrix Funding
Pharmac announced, in February, it was looking to extend funded access to Shingrix, the new vaccination for shingles, to immunocompromised people over 18 years old. However, the proposal listed specific treatments and conditions eligible. While we were pleased to see people who are pre- or post-haematopoietic stem cell transplant included, we were disappointed that MS […]